United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-038_58276aee-999f-8f59-e063-6394a90afa32
- Product NDC
- 85766-038
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- Sportpharm LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100412
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (85766-038-04) / 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 85766-038-04
- 1 BLISTER PACK in 1 CARTON (85766-038-06) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 85766-038-06
- 1 BLISTER PACK in 1 CARTON (85766-038-10) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 85766-038-10
- 2 BLISTER PACK in 1 CARTON (85766-038-20) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 85766-038-20
- 24 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (85766-038-24) · 85766-038-24
- 3 BLISTER PACK in 1 CARTON (85766-038-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 85766-038-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →